MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2024.03.025

Медицинская библиотека · Vaccine · 2024

Adverse events following immunisation: Prospective cohort study evaluating Australian children presenting to specialist immunisation clinics.

Stubbs Hannah, Palasanthiran Pamela, Koirala Archana, Lee Amelia, Duguid Robert C, Brogan Deidre, Wood Nicholas, Kandasamy Rama

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Prior experience of an adverse event following immunisation is a known barrier to vaccination. Limited Australian data evaluating adverse event recurrence among children exists to inform clinical decisions. We aimed to assess adverse event following immunisation recurrence among children with prior adverse events and to evaluate if family history increased adverse event risk.

METHODS

A prospective cohort study was conducted from March 3rd until August 18th, 2023. Children ≤ 16 years with prior adverse events following immunisation in themselves or family were recruited from specialist immunisation clinics at two quaternary paediatric hospitals. Adverse event outcomes were collected via surveys administered at presentation, three, and eight days post vaccination, and analysed by key characteristics and potential risk factors.

RESULTS

Forty three of forty nine (43/49, 87.8 %) children enrolled received further vaccines. Of those who completed the follow up surveys, 50.0 % (16/32) reported an adverse event. Recurrence of prior adverse events occurred for 23.3 % (10/43, 95 % CI: 11.8 % - 38.6 %) of the cohort. Two of twelve (2/12, 16.7 %) participants with prior serious adverse events who received further vaccines reported a serious adverse event recurrence. No post review serious adverse events were observed in children with prior non serious adverse events. Neurological conditions were a risk factor for prior (neurological condition 3/3 versus no neurological condition 2/40, p < 0.001) and post review (neurological condition 2/3 versus no neurological condition 0/28, p = 0.006) post vaccination seizures. Family history had no relationship to post review adverse events (family history 5/8 versus no family history 11/23, p = 0.685).

CONCLUSION

Revaccination is safe for the majority of children with a personal or family history of adverse event following immunisation.

Для цитирования: Stubbs Hannah, Palasanthiran Pamela, Koirala Archana, Lee Amelia, Duguid Robert C, Brogan Deidre, Wood Nicholas, Kandasamy Rama. Adverse events following immunisation: Prospective cohort study evaluating Australian children presenting to specialist immunisation clinics.. Vaccine. 2024. DOI: 10.1016/j.vaccine.2024.03.025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.